ATE218345T1 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number: ATE218345T1
Authority: AT; Austria
Prior art keywords: represent; spinocerebellar degeneration; drugs; ococh3; hydrogen
Prior art date: 1994-08-05

Application number

AT95927966T

Other languages

English (en)

Inventor

Tetsuo Sakai

Yasunobu Antoku

Toyojiro Matsuishi

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-05

Filing date

1995-08-04

Publication date

2002-06-15

1995-08-04 Application filed by Suntory Ltd filed Critical Suntory Ltd

2002-06-15 Application granted granted Critical

2002-06-15 Publication of ATE218345T1 publication Critical patent/ATE218345T1/de

Links

206010008025 Cerebellar ataxia Diseases 0.000 title abstract 2
208000010112 Spinocerebellar Degenerations Diseases 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT95927966T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration ATE218345T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP18468294		1994-08-05
PCT/JP1995/001550 WO1996003989A1 (en)	1994-08-05	1995-08-04	Remedy for spinocerebellar degeneration

Publications (1)

Publication Number	Publication Date
ATE218345T1 true ATE218345T1 (de)	2002-06-15

Family

ID=16157531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95927966T ATE218345T1 (de)	1994-08-05	1995-08-04	Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country	Link
US (1)	US5753656A (de)
EP (1)	EP0722731B1 (de)
AT (1)	ATE218345T1 (de)
DE (1)	DE69526918T2 (de)
ES (1)	ES2177654T3 (de)
WO (1)	WO1996003989A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4418097A1 (de)	1994-05-24	1995-11-30	Cassella Ag	Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
IL123884A (en) *	1996-07-31	2002-04-21	Cmic Co Ltd	6-formylpterin derivatives and oligomers and polymers thereof, for use as active oxygen scavengers
DE69725721T3 (de)	1996-08-30	2007-10-31	Daiichi Asubio Pharma Co., Ltd.	Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
JP4306825B2 (ja)	1998-02-27	2009-08-05	アスビオファーマ株式会社	インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7167844B1 (en)	1999-12-22	2007-01-23	Accenture Llp	Electronic menu document creator in a virtual financial environment
US7610233B1 (en)	1999-12-22	2009-10-27	Accenture, Llp	System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US6623754B2 (en) *	2001-05-21	2003-09-23	Noveon Ip Holdings Corp.	Dosage form of N-acetyl cysteine
US20060110325A1 (en) *	2003-02-21	2006-05-25	Hinz Martin C	Serotonin and catecholamine segment optimization technology
US20070293571A1 (en) *	2006-06-08	2007-12-20	Hinz Martin C	Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
US20030181509A1 (en) *	2002-03-21	2003-09-25	Hinz Martin C.	Serotonin and catecholamine system segment optimization technology
US20090311795A1 (en) *	2002-03-21	2009-12-17	Hinz Martin C	Bilateral control of functions traditionally regulated by only serotonin or only dopamine
DE10260263A1 (de) *	2002-12-20	2004-07-15	Biocrates Life Sciences Gmbh	Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US7442372B2 (en)	2003-08-29	2008-10-28	Biomarin Pharmaceutical Inc.	Delivery of therapeutic compounds to the brain and other tissues
CA2543315A1 (en) *	2003-11-13	2005-06-02	The General Hospital Corporation	Methods for treating pain
PL3138566T3 (pl)	2003-11-17	2022-03-07	Biomarin Pharmaceutical Inc.	Leczenie fenyloketonurii z użyciem bh4
JP4964587B2 (ja) *	2004-05-11	2012-07-04	第一三共株式会社	Ｂｈ４反応性高フェニルアラニン血症治療剤
EP2436379A1 (de)	2004-11-17	2012-04-04	BioMarin Pharmaceutical Inc.	Stabile Tablettenformulierung
EP1819340A2 (de) *	2004-12-08	2007-08-22	Biomarin Pharmaceutical Inc.	Verfahren und zusammensetzungen zur behandlung von lungenhypertonie bei neugeborenen
AU2006321942A1 (en) *	2005-12-05	2007-06-14	Biomarin Pharmaceutical Inc.	Methods and compositions for the treatment of disease
CA2675134A1 (en) *	2007-01-12	2008-07-24	Biomarin Pharmaceutical Inc.	Pterin analogs
WO2008089148A1 (en) *	2007-01-12	2008-07-24	Biomarin Pharmaceutical Inc.	Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
PL2139485T3 (pl)	2007-04-11	2013-03-29	Biomarin Pharm Inc	Metoda podawania tetrahydrobiopteryny, powiązane kompozycje i sposoby pomiaru
AU2008347005B2 (en) *	2008-01-03	2013-10-03	Biomarin Pharmaceutical Inc.	Pterin analog for treating BH4 responsive condition
WO2011132435A1 (ja)	2010-04-22	2011-10-27	学校法人日本大学	脳機能障害予防・改善用の薬剤及び飲食物
US9216178B2 (en)	2011-11-02	2015-12-22	Biomarin Pharmaceutical Inc.	Dry blend formulation of tetrahydrobiopterin
MA46972A (fr)	2016-11-29	2019-10-09	Censa Pharmaceuticals Inc	Forme polymorphe de sépiaptérine
MA46973A (fr)	2016-11-29	2019-10-09	Censa Pharmaceuticals Inc	Polymorphes de sépiaptérine et leurs sels
RU2728717C1 (ru) *	2017-06-02	2020-07-30	ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд.	Средство для профилактики или лечения спиноцеребеллярной атаксии
CA3073957A1 (en)	2017-09-01	2019-03-07	Censa Pharmaceuticals Inc.	Pharmaceutical compositions comprising sepiapterin and uses thereof
US20210269443A1 (en) *	2018-05-30	2021-09-02	Ptc Therapeutics Mp, Inc.	Pharmaceutically acceptable salts of sepiapterin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5925323A (ja)	1982-03-03	1984-02-09	鐘淵化学工業株式会社	プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
JPS5976086A (ja) *	1982-09-20	1984-04-28	ザ　ウエルカム　フアウンデ−シヨン　リミテツド	プテリジン化合物
JPS61277618A (ja) *	1985-06-04	1986-12-08	Suntory Ltd	自閉症治療剤
JP2588191B2 (ja) *	1987-04-24	1997-03-05	サントリー株式会社	悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
ATE180493T1 (de) *	1991-11-16	1999-06-15	Suntory Ltd	Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin

1995
- 1995-08-04 AT AT95927966T patent/ATE218345T1/de not_active IP Right Cessation
- 1995-08-04 US US08/632,412 patent/US5753656A/en not_active Expired - Lifetime
- 1995-08-04 EP EP95927966A patent/EP0722731B1/de not_active Expired - Lifetime
- 1995-08-04 DE DE69526918T patent/DE69526918T2/de not_active Expired - Lifetime
- 1995-08-04 ES ES95927966T patent/ES2177654T3/es not_active Expired - Lifetime
- 1995-08-04 WO PCT/JP1995/001550 patent/WO1996003989A1/ja not_active Ceased

Also Published As

Publication number	Publication date
EP0722731B1 (de)	2002-06-05
DE69526918D1 (de)	2002-07-11
EP0722731A4 (de)	1998-03-04
EP0722731A1 (de)	1996-07-24
WO1996003989A1 (en)	1996-02-15
US5753656A (en)	1998-05-19
DE69526918T2 (de)	2002-12-19
ES2177654T3 (es)	2002-12-16

Legal Events

Date	Code	Title	Description
2002-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE218345T1 (de)	2002-06-15	Arzneimittel gegen spinocerebellare degeneration
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
AU8794291A (en)	1992-05-21	New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
WO2001072728A3 (en)	2002-07-18	Novel piperazine derivatives
AU7278500A (en)	2001-03-13	Fungicides
AU1608692A (en)	1992-11-12	Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt)	2003-04-30	Compostos farmaceuticamente activos
EP0630898A4 (de)	1995-04-26	Heilmittel für thrombozytopenia.
CA2336412A1 (en)	2000-01-13	Medicament for treatment of diabetes
EP1182193A4 (de)	2002-09-11	Medikamente gegen neuropathische schmerzen
ES2072223B1 (es)	1996-03-16	Liposomas encapsulando doxorubicina.
IL114785A0 (en)	1995-11-27	Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT59139A (en)	1992-04-28	Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
FI924285A0 (fi)	1992-09-24	4-desoxi-4 -epipodophyllotoxinderivat eller ett farmaceutiskt acceptabelt salt daerav.
EP1241158A4 (de)	2004-02-11	Verbindung mit hydroxycarbonyl-halogenalkyl-seitenkette
WO2000046210A3 (en)	2000-12-14	New process for preparing pesticidal intermediates
EP0712398A1 (de)	1996-05-22	Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
IL166513A0 (en)	2006-01-15	Lamellarin derivatives and pharmaceutical compositions containing the same
EP0816366A4 (de)	1998-07-08	Imidazothiazolverbindungen
DE69722610D1 (de)	2003-07-10	Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
EP1026162A4 (de)	2001-01-17	Antirheumatika
FI911138A0 (fi)	1991-03-07	Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE69925225D1 (de)	2005-06-16	Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
MX9206930A (es)	1993-06-01	Nuevos compuestos
EP1136488A4 (de)	2002-06-12	Sf2809-i, ii, iii. vi, v und vi-verbindungen mit chymase-inhibierender wirkung